The administration of F. plautii through gavage resulted in reduced inflammation levels and potent inhibition of IL-17 signaling in DSS-induced mouse colitis, which was associated with lipophosphatidic acid-mediated inhibition of IL-17 by F. plautii. This evidence concerns the gene IL17A and colitis.